US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist
  • 13.0100
  • +0.4300+3.42%
Close Oct 31 16:00 ET
  • 12.7500
  • -0.2600-2.00%
Post 19:04 ET
126.20MMarket Cap0.07P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avalo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q4571.000K / 300.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q4571.000K / 300.000K--

Unlock Free Earnings Estimates

Avalo Therapeutics Earnings Reports

  • Avalo Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 19:05

  • Avalo Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Jul 12 04:20

  • Avalo Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 19:34

  • Avalo Therapeutics | 10-K: FY2023 Annual Report

    Mar 30 04:08

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 24, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data